thromboDx BV

About:

thromboDx is a molecular diagnostics company that develops and commercializes blood-based, platelet-powered diagnostics.

Website: http://www.thrombodx.nl

Twitter/X: thrombodx

Description:

thromboDx BV is a molecular diagnostics company that develops and commercializes blood-based diagnostics through its proprietary platelet-powered technology platform and has its offices in Amsterdam, The Netherlands. The technology platform addresses the need for an easily accessible, minimally invasive source for high quality disease-specific nucleic acids in several markets. thromboDx BV targets three major markets: 1. Cancer Diagnostics 2. Infectious Disease Monitoring 3. Prenatal Testing thromboDx BV is embedded in an excellent scientific and clinical infrastructure at the Cancer Center Amsterdam that allows rapid access to patient cohorts and clinical studies. Medical diagnostics and oncology are key focus points and the company has access to top end infrastructure and labs for its scientific work. Collaborations have been established with several research groups at Cancer Center Amsterdam, the University of Umea in Sweden and with Harvard Medical School and Massachusetts General Hospital in Boston.

Total Funding Amount:

621000 EUR

Headquarters Location:

Amsterdam, Noord-Holland, The Netherlands

Founded Date:

2012-01-01

Contact Email:

info(AT)thrombodx.com

Founders:

Bastiaan van der Baan, Jonas Nilsson, Robert AL, Rolf Jan Rutten, Tom Würdinger

Number of Employees:

1-10

Last Funding Date:

2013-12-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai